Novo Nordisk Aktie
47,07EUR | -1,25EUR | -2,58% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
---|---|---|---|---|---|---|
UBS AG | 340,00DKK | -2,86% | 05.09.25 | |||
JP Morgan Chase & Co. | 500,00DKK | 42,86% | 04.09.25 | |||
Deutsche Bank AG | 600,00DKK | 71,43% | 27.08.25 | |||
Bernstein Research | 620,00DKK | 77,14% | 26.08.25 | |||
Goldman Sachs Group Inc. | 392,00DKK | 12,00% | 08.08.25 | |||
Jefferies & Company Inc. | 415,00DKK | 18,57% | 06.08.25 | |||
Barclays Capital | 375,00DKK | 7,14% | 30.07.25 | |||
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 610,00DKK | 74,29% | 15.07.25 |
Historische Rating-Entwicklung
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|